In non-small cell lung cancer (NSCLC), higher tumoral hCTR1 expression has repeatedly correlated with increased intratumoral platinum accumulation, higher response rates and longer progression-free survival [147,228,229], and similar associations have been described in muscle-invasive bladder, ovarian and endometrial cancers treated with platinum-containing chemotherapy [230,231]. Here, SLC31A1 is linked to non-small cell lung carcinoma.